Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Jazz Pharmaceuticals plc

NASDAQ: JAZZ · Life Sciences · 12 alerts · CIK 1232524

Share price
$239.77Close, Nov 16
Market cap
$15.4B
Shares outstanding
64.19MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Jazz Pharmaceuticals plc filings on SEC EDGAR ↗

4:16 PM ET 8-K
Loan & Debt

Jazz Pharmaceuticals $1.9B Debt Financing with Bank of America, N.A.

Jazz Pharmaceuticals' subsidiary, Jazz Financing Lux S.à r.l., entered into a repricing amendment to its credit agreement to refinance $1.895 billion in outstanding term loans. The new Tranche B-3 Dollar Term Loans extend the maturity date from May 2028 to May 2033 and reduce the interest rate margin by 50 basis points to Term SOFR plus 1.75%.

Value
$1.9B
Counterparty
Bank of America, N.A.
Term
through May 2033

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.